Teens Who Use Drugs Show Unique Brain Development Linked to Dopamine

Understanding the Link Between Brain Chemistry and Teen Behavior

Adolescence is a time of significant change, both physically and mentally. During this period, teens often exhibit increased curiosity, a heightened sensitivity to rewards, and a tendency to take risks—including experimenting with substances like alcohol or drugs. A recent study published in Developmental Cognitive Neuroscience has uncovered new insights into how brain chemistry during adolescence may influence these behaviors.

The research suggests that variations in dopamine-related brain activity could help explain why some teens are more likely to try substances and why others need stronger external rewards to stay focused on cognitive tasks. Dopamine, a neurotransmitter involved in reward processing and motivation, plays a critical role in shaping behavior. The study found that slower increases in a brain chemistry marker linked to dopamine function were associated with both substance use and a greater reliance on rewards for cognitive performance.

The Role of Dopamine in Adolescent Development

Dopamine is essential for regulating feelings of pleasure and motivation. In adults with substance use disorders, there is often a reduced availability of dopamine receptors and transporters in the basal ganglia—a brain region involved in reward processing and self-control. However, much less is known about how early changes in dopamine-related brain development might contribute to substance use in adolescents.

Measuring dopamine directly in the brain is challenging, especially in younger individuals. To address this, researchers have turned to an alternative: brain tissue iron. Iron is necessary for dopamine synthesis and storage, and it accumulates in dopamine-rich areas of the brain during adolescence. By using magnetic resonance imaging (MRI), scientists can indirectly assess dopamine-related brain development by tracking tissue iron levels in the basal ganglia.

Methodology and Key Findings

The study followed 168 adolescents from sixth through eleventh grade, collecting brain scans at multiple timepoints between the ages of 12 and 18. Over the course of the research, participants completed cognitive tasks and self-reported their substance use. At the final timepoint, a subset of 76 participants also took part in the “Planets Task,” which measured cognitive control under different reward conditions.

Using T2-weighted MRI signals, researchers analyzed four subregions of the basal ganglia: the caudate, putamen, pallidum, and nucleus accumbens. Lower T2 signals indicate higher iron concentration, which is associated with more active dopamine systems.

The results showed that tissue iron levels generally increased during adolescence, reflecting normal brain development. However, teens who reported substance use—ranging from alcohol and marijuana to vaping—had a slower rate of increase in iron levels, particularly in the nucleus accumbens. This area is linked to assigning motivational value to rewards and has been connected to substance use risk.

Teens who had never used substances showed a steeper increase in nucleus accumbens iron than those who had. This difference was not influenced by factors such as income, race, sex, or ADHD diagnosis. While it's unclear whether lower iron accumulation causes substance use or is a result of it, the findings suggest that teens with less dopamine-related activity may be more drawn to substances as a way to compensate for reduced sensitivity to natural rewards.

Incentive-Dependent vs. Incentive-Independent Teens

The study also explored how tissue iron levels related to cognitive performance under different reward conditions. Participants who relied more on incentives to improve their cognitive control—referred to as “incentive-dependent”—had lower iron accumulation in the putamen, a brain region involved in motor control and task execution. In contrast, teens whose performance remained stable across all reward conditions—“incentive-independent” individuals—showed stronger age-related increases in putamen tissue iron.

These findings suggest that adolescents with lower dopamine-related activity in the putamen may require stronger external motivation to perform at the same level as their peers. However, the study did not find a direct link between tissue iron levels and changes in incentive-related brain activation, indicating that these factors may operate through different processes.

Limitations and Future Directions

While the study provides valuable insights, it does not prove causation. Researchers cannot determine whether reduced iron accumulation leads to substance use or if even mild early use affects brain development. Additionally, incentive-boosted cognitive control and brain activity were only measured at the final timepoint, limiting the ability to track developmental changes over time.

Tissue iron is a useful proxy for dopamine-related physiology, but it is not a direct measure of dopamine function. More research is needed to understand how iron levels reflect broader changes in the dopamine system. As Flannery noted, “It is important to note that this study did not directly assess brain tissue iron but instead relied on a magnetic resonance-based estimation.”

Despite these limitations, the study highlights the complex relationship between brain chemistry and adolescent behavior. It underscores the importance of understanding how neurodevelopmental differences might influence health-related decisions and behaviors in teens.